Healthcare professionals discuss the vital role of pharmacy teams in managing complex patient care, emphasizing collaboration and medication safety. In this episode, ‘The Role of Pharmacy in ...
Surgeons at Cleveland Clinic completed the first commericial procedure using the Hugo robot-assisted surgery system in the US. The first US commercial surgical case using the Hugo robot-assisted ...
In this episode, host Amy Pearlman, MD, sits down with Bruce R. Kava, MD, for a a discussion on his career path from oncologic surgery to sexual medicine, revision penile prosthetics, and cancer ...
The conversation explores the growing role of at-home semen testing kits as screening tools, their advantages in accessibility and privacy, and their limitations compared with in-lab testing. In this ...
Adam B. Weiner, MD, is joined by Brian M. Shuch, MD, for a concise yet wide-ranging update on the evolving role of adjuvant therapy in renal cell carcinoma. In this episode of The UroOnc Minute, host ...
VYBRIQUE is a sildenafil oral film formulated for discreet, water-free administration, aiming to reduce use barriers for patients for whom privacy and convenience influence ED treatment adherence. A ...
Novant Health approved SUREcore and coreCARE after value analysis identified recurrent prostate core fragmentation and processing gaps that can impair complete sectioning and diagnostic confidence.
Francis Medical’s Vanquish platform delivers transurethral, image-guided convective water vapor thermal ablation and received FDA 510(k) clearance in December 2025 based on VAPOR 2. Six-month data ...
The EMA's CHMP recommends expanding niraparib and abiraterone acetate use for mHSPC patients with BRCA1/2 mutations, based on phase 3 AMPLITUDE trial results. The AMPLITUDE trial showed significant ...
PDS01ADC targets DNA-histone epitopes in necrotic tumor regions, showing synergy with docetaxel in preclinical models. The trial enrolled 16 mCRPC patients, with a median progression-free survival of ...
AVA-291 is a novel testosterone formulation for women, designed to resist aromatization and reduce breast cancer risk. Data shows AVA-291 has a 1,000-fold lower potential to stimulate breast cancer ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results